Literature DB >> 1935935

Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases.

B Maras1, P Dominici, D Barra, F Bossa, C B Voltattorni.   

Abstract

The complete amino acid sequence of pig kidney 3,4-dihydroxyphenylalanine (Dopa) decarboxylase is reported. The sequence was determined from analysis of peptides isolated after tryptic and cyanogen bromide cleavages of the enzyme. Each subunit is made up of 485 residues, corresponding to a molecular mass of 53858 Da. The N-terminus of the polypeptide chain is an acetylated methionyl residue. A number of structural features, previously shown to be important for the structure and function of the enzyme, could be localized along the polypeptide chain. Comparison of the primary structure with the known cDNA-deduced sequences of other Dopa decarboxylases (i.e. the human, bovine, rat, guinea-pig and Drosophila enzymes) reveals 50% identity. The identity increases to 73%, if the comparison is restricted to the mammalian sequences. Comparison with other aromatic and non-aromatic decarboxylases allows some consideration to be made in terms of structure/function and evolutionary relationships in this class of enzymes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1935935     DOI: 10.1111/j.1432-1033.1991.tb16295.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes.

Authors:  P S Moore; P Dominici; C Borri Voltattorni
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

2.  Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.

Authors:  P Dominici; P S Moore; S Castellani; M Bertoldi; C B Voltattorni
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

3.  Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency.

Authors:  Riccardo Montioli; Barbara Cellini; Carla Borri Voltattorni
Journal:  J Inherit Metab Dis       Date:  2011-05-04       Impact factor: 4.982

4.  Cloning and expression of human placental L-Dopa decarboxylase.

Authors:  Maria-Zaharenia Siaterli; Dido Vassilacopoulou; Emmanuel G Fragoulis
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

5.  Dissociation, unfolding and refolding trials of pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase.

Authors:  P Dominici; P S Moore; C Borri Voltattorni
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

6.  Interaction of human Dopa decarboxylase with L-Dopa: spectroscopic and kinetic studies as a function of pH.

Authors:  Riccardo Montioli; Barbara Cellini; Mirco Dindo; Elisa Oppici; Carla Borri Voltattorni
Journal:  Biomed Res Int       Date:  2013-05-26       Impact factor: 3.411

7.  Biochemical and computational approaches to improve the clinical treatment of dopa decarboxylase-related diseases: an overview.

Authors:  Barbara Cellini; Riccardo Montioli; Elisa Oppici; Carla Borri Voltattorni
Journal:  Open Biochem J       Date:  2012-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.